| (Values in U.S. Thousands) | Dec, 2021 | Dec, 2020 | Dec, 2019 | Dec, 2025 | Dec, 2025 |
| Sales | 16,740 | 13,280 | 15,420 | 0 | 0 |
| Sales Growth | +26.05% | -13.88% | unch | unch | unch |
| Net Income | -361,790 | -262,190 | -236,800 | 0 | 0 |
| Net Income Growth | -37.99% | -10.72% | unch | unch | unch |
Zymergen Inc (ZY)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Zymergen Inc. is a biofacturing company. It design, develop and manufacture bio-based breakthrough products. Zymergen Inc. is based in EMERYVILLE, Calif.
Fiscal Year End Date: 12/31